(Q41181011)

English

The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial

scientific article published on 3 June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 September 2017

The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial (English)

1 reference

Europe PubMed Central

27 September 2017

0 references

0 references

object named as

Helen Mearns

2

0 references

object named as

Peter Andersen

8

0 references

object named as

Sean Bennett

7

0 references

13

object named as

Mark Hatherill

1 reference

Europe PubMed Central

27 September 2017

Willem Albert Hanekom

11

object named as

Willem A Hanekom

1 reference

Europe PubMed Central

27 September 2017

Thomas J Scriba

14

object named as

Thomas J Scriba

1 reference

Europe PubMed Central

27 September 2017

author name string

Hennie Geldenhuys

1

1 reference

Europe PubMed Central

27 September 2017

David J C Miles

3

1 reference

Europe PubMed Central

27 September 2017

Michele Tameris

4

1 reference

Europe PubMed Central

27 September 2017

David Hokey

5

1 reference

Europe PubMed Central

27 September 2017

Zhongkai Shi

6

1 reference

Europe PubMed Central

27 September 2017

Ingrid Kromann

9

1 reference

Europe PubMed Central

27 September 2017

Søren T Hoff

10

1 reference

Europe PubMed Central

27 September 2017

Hassan Mahomed

12

1 reference

Europe PubMed Central

27 September 2017

H4:IC31 Trial Study Group

15

1 reference

Europe PubMed Central

27 September 2017

Michele van Rooyen

16

1 reference

Europe PubMed Central

27 September 2017

J Bruce McClain

17

1 reference

Europe PubMed Central

27 September 2017

Robert Ryall

18

1 reference

Europe PubMed Central

27 September 2017

Guy de Bruyn

19

1 reference

Europe PubMed Central

27 September 2017

H4:IC31 Trial Study Groupa

20

1 reference

Europe PubMed Central

27 September 2017

language of work or name

0 references

publication date

3 June 2015

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

27 September 2017

33

1 reference

Europe PubMed Central

27 September 2017

30

1 reference

Europe PubMed Central

27 September 2017

3592-3599

1 reference

Europe PubMed Central

27 September 2017

A historical and molecular phylogeny of BCG strains.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

Immunological memory transferred with CD4 T cells specific for tuberculosis antigens Ag85B-TB10.4: persisting antigen enhances protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

SPICE: exploration and analysis of post-cytometric complex multivariate datasets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

Phenotype and function of human T lymphocyte subsets: consensus and issues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

Functional and phenotypic characterization of tetanus toxoid-specific human CD4+ T cells following re-immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

Control of chronic mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.05.036

7 January 2021

Identifiers

10.1016/J.VACCINE.2015.05.036

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

27 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41181011&oldid=1917069903"